Support PenkeLRI Investments, LLC
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARES.NYSE | Ares Management LP | USA | Financial Services | Asset Management | 2024-09-30 | 1.288 | 42.62 | 2.5m | $68.7m | $470.6m |
| |||||||||||||
| CYTO.NASDAQ | Altamira Therapeutics Ltd | USA | Healthcare | Biotechnology | 2024-03-31 | 0 | 0 | 1.00 | $1.90 | $0.12 |
|
Trades
Buys
Report date: 2024-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ARES.NYSE | 2.8m | - | 385.4m | 125-150 | $181.06 | 44.6% |
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CYTO.NASDAQ | 1.00 | - | 2.13 | 2-4 | $0.12 | -92.5% |
Sells
Report date: 2024-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CYTO.NASDAQ | -1.00 | -100.0 | -1.00 | 1-2 | $0.12 | -80.0% |
Reduces
Report date: 2024-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ARES.NYSE | -223.3k | -7.9 | -32.4m | 128-160 | $181.06 | 41.5% |
Comments
How you think about this?